Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Aug 1;373(Pt 3):767–774. doi: 10.1042/BJ20030150

A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.

Hideyuki Mitomo 1, Ryo Kato 1, Akiko Ito 1, Shiho Kasamatsu 1, Yoji Ikegami 1, Isao Kii 1, Akira Kudo 1, Eiry Kobatake 1, Yasuhiro Sumino 1, Toshihisa Ishikawa 1
PMCID: PMC1223553  PMID: 12741957

Abstract

Overexpression of the ATP-binding cassette transporter ABCG2 reportedly causes multidrug resistance, whereas altered drug-resistance profiles and substrate specificity are implicated for certain variant forms of ABCG2. At least three variant forms of ABCG2 have been hitherto documented on the basis of their amino acid moieties (i.e., arginine, glycine and threonine) at position 482. In the present study we have generated those ABCG2 variants by site-directed mutagenesis and expressed them in HEK-293 cells. Exogenous expression of the Arg(482), Gly(482), and Thr(482) variant forms of ABCG2 conferred HEK-293 cell resistance toward mitoxantrone 15-, 47- and 54-fold, respectively, as compared with mock-transfected HEK-293 cells. The transport activity of those variants was examined by using plasma-membrane vesicles prepared from ABCG2-overexpressing HEK-293 cells. [Arg(482)]ABCG2 transports [(3)H]methotrexate in an ATP-dependent manner; however, no transport activity was observed with the other variants (Gly(482) and Thr(482)). Transport of methotrexate by [Arg(482)]ABCG2 was significantly inhibited by mitoxantrone, doxorubicin and rhodamine 123, but not by S -octylglutathione. Furthermore, ABCG2 was found to exist in the plasma membrane as a homodimer bound via cysteinyl disulphide bond(s). Treatment with mercaptoethanol decreased its apparent molecular mass from 140 to 70 kDa. Nevertheless, ATP-dependent transport of methotrexate by [Arg(482)]ABCG2 was little affected by such mercaptoethanol treatment. It is concluded that Arg(482) is a critical amino acid moiety in the substrate specificity and transport of ABCG2 for certain drugs, such as methotrexate.

Full Text

The Full Text of this article is available as a PDF (191.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen John D., Jackson Sonja C., Schinkel Alfred H. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance. Cancer Res. 2002 Apr 15;62(8):2294–2299. [PubMed] [Google Scholar]
  2. Allikmets R., Schriml L. M., Hutchinson A., Romano-Spica V., Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 1998 Dec 1;58(23):5337–5339. [PubMed] [Google Scholar]
  3. Ambudkar S. V., Dey S., Hrycyna C. A., Ramachandra M., Pastan I., Gottesman M. M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol. 1999;39:361–398. doi: 10.1146/annurev.pharmtox.39.1.361. [DOI] [PubMed] [Google Scholar]
  4. Borst P., Elferink R. Oude. Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2001 Nov 9;71:537–592. doi: 10.1146/annurev.biochem.71.102301.093055. [DOI] [PubMed] [Google Scholar]
  5. Brangi M., Litman T., Ciotti M., Nishiyama K., Kohlhagen G., Takimoto C., Robey R., Pommier Y., Fojo T., Bates S. E. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Res. 1999 Dec 1;59(23):5938–5946. [PubMed] [Google Scholar]
  6. Chen Zhe-Sheng, Lee Kun, Walther Susan, Raftogianis Rebecca Blanchard, Kuwano Michihiko, Zeng Hao, Kruh Gary D. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 2002 Jun 1;62(11):3144–3150. [PubMed] [Google Scholar]
  7. Dean M., Rzhetsky A., Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001 Jul;11(7):1156–1166. doi: 10.1101/gr.184901. [DOI] [PubMed] [Google Scholar]
  8. Doyle L. A., Yang W., Abruzzo L. V., Krogmann T., Gao Y., Rishi A. K., Ross D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15665–15670. doi: 10.1073/pnas.95.26.15665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hazlehurst L. A., Foley N. E., Gleason-Guzman M. C., Hacker M. P., Cress A. E., Greenberger L. W., De Jong M. C., Dalton W. S. Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res. 1999 Mar 1;59(5):1021–1028. [PubMed] [Google Scholar]
  10. Honjo Y., Hrycyna C. A., Yan Q. W., Medina-Pérez W. Y., Robey R. W., van de Laar A., Litman T., Dean M., Bates S. E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. 2001 Sep 15;61(18):6635–6639. [PubMed] [Google Scholar]
  11. Hooijberg J. H., Broxterman H. J., Kool M., Assaraf Y. G., Peters G. J., Noordhuis P., Scheper R. J., Borst P., Pinedo H. M., Jansen G. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 1999 Jun 1;59(11):2532–2535. [PubMed] [Google Scholar]
  12. Iida Aritoshi, Saito Susumu, Sekine Akihiro, Mishima Chihiro, Kitamura Yuri, Kondo Kimei, Harigae Satoko, Osawa Saori, Nakamura Yusuke. Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8. J Hum Genet. 2002;47(6):285–310. doi: 10.1007/s100380200041. [DOI] [PubMed] [Google Scholar]
  13. Ishikawa T. ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles. J Biol Chem. 1989 Oct 15;264(29):17343–17348. [PubMed] [Google Scholar]
  14. Kage Kumie, Tsukahara Satomi, Sugiyama Tomomi, Asada Sakiyo, Ishikawa Etsuko, Tsuruo Takashi, Sugimoto Yoshikazu. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer. 2002 Feb 10;97(5):626–630. doi: 10.1002/ijc.10100. [DOI] [PubMed] [Google Scholar]
  15. Klein I., Sarkadi B., Váradi A. An inventory of the human ABC proteins. Biochim Biophys Acta. 1999 Dec 6;1461(2):237–262. doi: 10.1016/s0005-2736(99)00161-3. [DOI] [PubMed] [Google Scholar]
  16. Komatani H., Kotani H., Hara Y., Nakagawa R., Matsumoto M., Arakawa H., Nishimura S. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res. 2001 Apr 1;61(7):2827–2832. [PubMed] [Google Scholar]
  17. Kool M., van der Linden M., de Haas M., Scheffer G. L., de Vree J. M., Smith A. J., Jansen G., Peters G. J., Ponne N., Scheper R. J. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6914–6919. doi: 10.1073/pnas.96.12.6914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol. 1997;40 (Suppl):S3–S8. doi: 10.1007/s002800051053. [DOI] [PubMed] [Google Scholar]
  19. Litman T., Brangi M., Hudson E., Fetsch P., Abati A., Ross D. D., Miyake K., Resau J. H., Bates S. E. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci. 2000 Jun;113(Pt 11):2011–2021. doi: 10.1242/jcs.113.11.2011. [DOI] [PubMed] [Google Scholar]
  20. Litman Thomas, Jensen Ulla, Hansen Alastair, Covitz Kuang-Ming, Zhan Zhirong, Fetsch Patricia, Abati Andrea, Hansen Paul Robert, Horn Thomas, Skovsgaard Torben. Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2. Biochim Biophys Acta. 2002 Sep 20;1565(1):6–16. doi: 10.1016/s0005-2736(02)00492-3. [DOI] [PubMed] [Google Scholar]
  21. Maliepaard M., Scheffer G. L., Faneyte I. F., van Gastelen M. A., Pijnenborg A. C., Schinkel A. H., van De Vijver M. J., Scheper R. J., Schellens J. H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001 Apr 15;61(8):3458–3464. [PubMed] [Google Scholar]
  22. Maliepaard M., van Gastelen M. A., de Jong L. A., Pluim D., van Waardenburg R. C., Ruevekamp-Helmers M. C., Floot B. G., Schellens J. H. Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 1999 Sep 15;59(18):4559–4563. [PubMed] [Google Scholar]
  23. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 1999 Jan 1;59(1):8–13. [PubMed] [Google Scholar]
  24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  25. Nakagawa Rinako, Hara Yoshikazu, Arakawa Hiroharu, Nishimura Susumu, Komatani Hideya. ABCG2 confers resistance to indolocarbazole compounds by ATP-dependent transport. Biochem Biophys Res Commun. 2002 Dec 13;299(4):669–675. doi: 10.1016/s0006-291x(02)02712-2. [DOI] [PubMed] [Google Scholar]
  26. Nakatomi K., Yoshikawa M., Oka M., Ikegami Y., Hayasaka S., Sano K., Shiozawa K., Kawabata S., Soda H., Ishikawa T. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem Biophys Res Commun. 2001 Nov 9;288(4):827–832. doi: 10.1006/bbrc.2001.5850. [DOI] [PubMed] [Google Scholar]
  27. Ozvegy Csilla, Váradi András, Sarkadi Balázs. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation. J Biol Chem. 2002 Oct 8;277(50):47980–47990. doi: 10.1074/jbc.M207857200. [DOI] [PubMed] [Google Scholar]
  28. Rabindran S. K., He H., Singh M., Brown E., Collins K. I., Annable T., Greenberger L. M. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res. 1998 Dec 15;58(24):5850–5858. [PubMed] [Google Scholar]
  29. Ross D. D. Novel mechanisms of drug resistance in leukemia. Leukemia. 2000 Mar;14(3):467–473. doi: 10.1038/sj.leu.2401694. [DOI] [PubMed] [Google Scholar]
  30. Ross D. D., Yang W., Abruzzo L. V., Dalton W. S., Schneider E., Lage H., Dietel M., Greenberger L., Cole S. P., Doyle L. A. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst. 1999 Mar 3;91(5):429–433. doi: 10.1093/jnci/91.5.429. [DOI] [PubMed] [Google Scholar]
  31. Saxena M., Henderson G. B. Identification of efflux systems for large anions and anionic conjugates as the mediators of methotrexate efflux in L1210 Cells. Biochem Pharmacol. 1996 Apr 12;51(7):974–982. doi: 10.1016/0006-2952(96)00051-2. [DOI] [PubMed] [Google Scholar]
  32. Schlemmer S. R., Sirotnak F. M. Energy-dependent efflux of methotrexate in L1210 leukemia cells. Evidence for the role of an ATPase obtained with inside-out plasma membrane vesicles. J Biol Chem. 1992 Jul 25;267(21):14746–14752. [PubMed] [Google Scholar]
  33. Schmitz G., Langmann T., Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res. 2001 Oct;42(10):1513–1520. [PubMed] [Google Scholar]
  34. Volk Erin L., Farley Kate M., Wu Yan, Li Fei, Robey Robert W., Schneider Erasmus. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res. 2002 Sep 1;62(17):5035–5040. [PubMed] [Google Scholar]
  35. Yoshikawa Megumi, Kasamatsu Shiho, Yasunaga Masa, Wang Guizhi, Ikegami Yoji, Yoshida Hisahiro, Tarui Shigeki, Yabuuchi Hikaru, Ishikawa Toshihisa. Does ABCG2 need a heterodimer partner? Expression and functional evaluation of ABCG2 (Arg 482)*. Drug Metab Pharmacokinet. 2002;17(2):130–135. doi: 10.2133/dmpk.17.130. [DOI] [PubMed] [Google Scholar]
  36. van der Kolk Dorina M., Vellenga Edo, Scheffer George L., Müller Michael, Bates Susan E., Scheper Rik J., de Vries Elisabeth G. E. Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood. 2002 May 15;99(10):3763–3770. doi: 10.1182/blood.v99.10.3763. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES